Matches in Nanopublications for { ?s ?p "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP825492.RABj-wzOtYQJ0XEPnrI-qwBe5z8J90-nwMx2XtlYknRuI130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825492.RABj-wzOtYQJ0XEPnrI-qwBe5z8J90-nwMx2XtlYknRuI130_provenance.
- NP651680.RAtkZCGjCxL4CyqF9WCNfblKIMUcu46RGDtza9MUaZncU130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651680.RAtkZCGjCxL4CyqF9WCNfblKIMUcu46RGDtza9MUaZncU130_provenance.
- NP644341.RAQMB6vdOhG38r6lq28baTx_y6ae1MW59uyPOj5AOUjNo130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644341.RAQMB6vdOhG38r6lq28baTx_y6ae1MW59uyPOj5AOUjNo130_provenance.
- NP570798.RA8v5i0l-pJmA3k_PjrAB5lMT1LDjXvFd-H-SOAdBenRs130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570798.RA8v5i0l-pJmA3k_PjrAB5lMT1LDjXvFd-H-SOAdBenRs130_provenance.
- NP712751.RA7YOcq1v2NL_0inHVlr5YD_bmOo38JMZ61NNnbHW3kTA130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712751.RA7YOcq1v2NL_0inHVlr5YD_bmOo38JMZ61NNnbHW3kTA130_provenance.